CXCL11/I-TAC Antibody (MM0210-9N26) - Azide and BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-12219
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
Block/Neutralize, Immunohistochemistry, Western Blot
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG2 Clone # MM0210-9N26
Format
Azide and BSA Free
Concentration
LYOPH mg/ml
Product Summary for CXCL11/I-TAC Antibody (MM0210-9N26) - Azide and BSA Free
Immunogen
Human recombinant CXCL11/I-TAC
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2
Scientific Data Images for CXCL11/I-TAC Antibody (MM0210-9N26) - Azide and BSA Free
Western Blot: CXCL11/I-TAC Antibody (MM0210-9N26)Azide and BSA Free [NBP2-12219]
Western Blot: CXCL11/I-TAC Antibody (MM0210-9N26) [NBP2-12219] - Lysates of HEK293 cells overexpressing human CXCL11Applications for CXCL11/I-TAC Antibody (MM0210-9N26) - Azide and BSA Free
Application
Recommended Usage
Immunohistochemistry
1:50-1:100
Western Blot
1:500-1:1000
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein G purified
Reconstitution
Reconstitute with sterilized PBS to a final concentration of 0.5 mg/ml.
Formulation
Lyophilized from a 0.2 um filtered solution in PBS. 0.025 mg size is provided in liquid form, PBS
Format
Azide and BSA Free
Preservative
No Preservative
Concentration
LYOPH mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: CXCL11/I-TAC
Additional CXCL11/I-TAC Products
Product Documents for CXCL11/I-TAC Antibody (MM0210-9N26) - Azide and BSA Free
Product Specific Notices for CXCL11/I-TAC Antibody (MM0210-9N26) - Azide and BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...